Airway administration of activated protein c in inflammatory...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/48 (2006.01) A61P 11/00 (2006.01)

Patent

CA 2612597

The present invention provides methods for the local treatment of acute and chronic extravascular pulmonary fibrin deposition and/or reducing unwanted effects associated with systemic administration of anticoagulants to a subject via airway administration to the subject by intratracheal, intrabronchial or intraalveolar routes of human activated protein C or biologically active derivatives thereof .

La présente invention a trait à des procédés pour le traitement local de dépôt de fibrines pulmonaires extravasculaires aigu et chronique et/ou la réduction d'effets indésirables associés à l'administration systémique d'anticoagulants à un sujet par l'administration aux voies aériennes au sujet par des voies intratrachéale, intrabronchique ou intraalvéolaire d'anticoagulants ou de leurs dérivés bioactifs.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Airway administration of activated protein c in inflammatory... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Airway administration of activated protein c in inflammatory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Airway administration of activated protein c in inflammatory... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1769865

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.